1 / 16

Changes to Rules and Regulations Pertaining to Epidemic and Communicable Disease Control Training

This update includes changes to the Rules and Regulations Pertaining to Epidemic and Communicable Disease Control. The changes provide clarification on who must report conditions and the required timing. It also introduces new reportable conditions and updates existing ones. Laboratories and individuals are required to comply with these changes effective November 14, 2015.

hspence
Download Presentation

Changes to Rules and Regulations Pertaining to Epidemic and Communicable Disease Control Training

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Changes to Rules and Regulations Pertaining to Epidemic and Communicable Disease Control Training Amanda Reiff, MPH Epidemiologist Jefferson County Public Health

  2. Update from CDPHE • Board of Health accepted the proposed changes on September 16, 2015 for the Rules and Regulations Pertaining to Epidemic and Communicable Disease Control (6 CCR 1009-1). • Will be effective on November 14, 2015 • For newly reportable conditions, the Colorado Electronic Disease Reporting System (CEDRS) will be available to receive reports on November 14, 2015

  3. Effective: October 15, 2014

  4. Changes • To better explain who must report conditions (Labs and/or individuals) and the required timing (24hrs vs 7 days): Regulations 1-3 were combined to create a single table.

  5. Changes • Accession number is required on all reported diseases with supporting laboratory results to comply with CDC reporting requirements and be able to link multiple tests performed on the same specimen.

  6. Changes • Clinical and reference laboratories are required to submit cultures or original clinical material for specific reportable conditions as listed in the reportable disease table. • Laboratories will submit bacterial culture isolates or patient clinical material that yields positive findings to the CDPHE Laboratory Services Division.

  7. Changes • Methicillin-resistant Staphylococcus aureus (MRSA) is deleted from the “Conditions Reportable by all Laboratories.”

  8. Changes • The definition of carbapenem-resistant Enterobacteriaceae (CRE) is changed. See regulations for new definition. • CDPHE will reach out individually to labs that are part of the Emerging Infections Program (EIP) to discuss reporting. • CRE remains a 7 day reportable condition CDC 2013

  9. Changes • Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is added as a 7 day reportable condition by laboratories. • CDPHE will reach out individually to labs that are part of the Emerging Infections Program (EIP) to discuss reporting.

  10. Changes • Viral hemorrhagic fever is added as a 24hr reportable condition by individuals AND laboratories. • Includes: Ebola virus disease, Crimean-Congo hemorrhagic fever, Lassa fever, Marburg fever, and more.

  11. Changes • Severe or Novel Coronavirus is added as a 24hr reportable condition by individuals AND Laboratories. • Includes: SARS and MERS-CoV

  12. Changes • Tularemia is changed from a 7 day reportable to 24hr reportable disease.

  13. Changes • Acute flaccid myelitis (AFM) is added as a 7 days reportable condition. • Definition can be found on CDPHE website

  14. Changes • When a laboratory performs a culture that is positive for Mycobacterium tuberculosis, the lab shall store the isolate until it receives a request from the state or local health department for the isolate OR the lab may fulfill this requirement by submitting the isolate to the state public health lab. • Once the isolate is received by the state public health laboratory it will be submitted to a CDC-contracted laboratory for genotype testing.

  15. Questions?

More Related